Sponsor Pipeline

Feldan Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07670858 Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC) Nodular Basal Cell Carcinoma Recruiting
Get alerts when Feldan Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free